Epidermal growth factor (EGF) binding to membranes immobilized in microtiter wells and estimation of EGF-related transforming growth factor activity |
| |
Authors: | Edwards S. Kimball Thomas C. Warren |
| |
Affiliation: | Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research Facility, Frederick, MD 21701 U.S.A. |
| |
Abstract: | The binding of radiolabeled epidermal growth factor (EGF) to immobilized A-431 target cell membranes coupled to polyvinyl chloride microtiter wells is described. Saturation curves and Scatchard analysis of the data indicate that the observed binding parameters are consistent with those previously reported. Binding capacity of the membranes are approx. 6.6 pmol EGF per mg membrane protein. Kinetics of 125I-EGF binding were slower, however, than reported for binding to membranes in suspension, although binding constants were not greatly different. The high- and low-affinity binding constants for 125I-EGF were calculated to be approximately 1 · 1012 M?1 and 2.5 · 109 M?1, respectively. Application of this technique in a competitive binding assay requires no more than 2.5 μg of membrane protein per assay, is essentially complete after 60 min, and facilitates screening of a large number of samples in a short time. Therefore, this will assist in the evaluation and quantitation of EGF and EGF-related transforming growth factor activity in physiological fluids. This technique may also be applied to analyses of other hormone-receptor systems. |
| |
Keywords: | Epidermal growth factor Membrane binding Solid-phase HPLC Receptor assay Transforming growth factor EGF epidermal growth factor HPLC high-performance liquid chromatography |
本文献已被 ScienceDirect 等数据库收录! |
|